PRG.L Regulatory News (PRG)

5 Feb 2007 16:38

Premier Research Group05 February 2007 For Immediate Release 5 February 2007 PREMIER RESEARCH GROUP Board Change Premier Research Group plc (AIM: PRG) ("Premier Research", "Company" or"Group"), the international pharmaceutical services group today announces thatGeoffrey Forster, is stepping down from his position as Non-Executive Chairmanwith immediate effect. Mr Forster considers it to be in the best interests ofthe Company that he stand down from the Board as he has recently increased hisresponsibilities with Torex Retail. Steve Harris, the remaining independent Non-Executive Director of PremierResearch, has agreed to act as Interim Non-Executive Chairman. For Further Information, please contact: Premier Research Group plcDr Simon Yaxley, Chief Executive Tel: 01344 458311 Buchanan CommunicationsLisa Baderoon / Rebecca Skye Dietrich Tel: 020 7466 5000 Evolution SecuritiesTim Worlledge / Simon Leathers Tel: 020 7071 4300 Notes to editors: About Premier Research Premier Research is a growing contract research organisation (CRO) involved inthe design and execution of clinical trials (Phases II-IV) on behalf ofpharmaceutical and biotechnology companies. Premier Research is established inthree therapeutic areas - oncology, CNS (central nervous system) andanti-infectives - with a strong underlying expertise in paediatrics. Through afocused approach to clinical management, the Company has built a reputation withits customers for delivery of its services, and has demonstrated organic growthfollowing its recent acquisitions. Premier Research has also established itselfas an active participant in the consolidation activity within the sector. This information is provided by RNS The company news service from the London Stock Exchange